CADL•benzinga•
Candel Therapeutics Announces Publication In Neuro-Oncology Of Phase 1b Clinical Trial Data On The Combination Of CAN-2409 And Nivolumab plus Standard Of Care In Newly Diagnosed High-Grade Glioma Patients
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga